Koninklijke Philips (PHG) Return on Capital Employed (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Return on Capital Employed came in at 8.38% in Q1 2026, up 125.0% year-on-year from 3.73% in Q1 2025, and up 3.85% quarter-over-quarter from 8.07% in Q4 2025.

Koninklijke Philips (PHG) Return on Capital Employed (2009 - 2026) Analysis & Trends

Koninklijke Philips' Return on Capital Employed history runs 9 years deep, the most recent figure standing at 8.38% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 125.0% year-over-year to 8.38% in Q1 2026; TTM through Mar 2026 was 8.38%, a 125.0% increase from a year earlier, with the FY2025 full-year figure at 7.39%, up 489.0% from the prior year.
  • Return on Capital Employed grew to 8.38% in Q1 2026 per PHG's latest filing, from 8.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 10.7% in Q2 2025 and bottomed at 7.14% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.61%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.24%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 8.02%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 11.13%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 24.24%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 8.38%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.30%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 11.57%

Historic Data

Download Data
DateValue
Mar 31, 2026 8.38%
Dec 31, 2025 8.07%
Sep 30, 2025 10.26%
Jun 30, 2025 10.70%
Mar 31, 2025 7.14%
Dec 31, 2017 6.92%
Sep 30, 2017 -3,797,659.91%
Jun 30, 2017 -3,834,913.75%
Mar 31, 2017 -3,480,017.13%
Dec 31, 2016 -3,567,638.32%
Sep 30, 2016 2.68%
Jun 30, 2016 3.01%
Mar 31, 2016 3.58%
Dec 31, 2015 4.22%
Sep 30, 2015 4.02%
Jun 30, 2015 -12.30%
Mar 31, 2015 -9.92%
Dec 31, 2014 -11.17%
Dec 31, 2013 -4.06%
Jun 30, 2013 13.21%